Abeona Therapeutics (ABEO) Profit After Tax (2011 - 2026)

Abeona Therapeutics' Profit After Tax history runs 16 years deep, the most recent figure standing at -$17.2 million for Q1 2026.

• In Q1 2026, Profit After Tax fell 42.38% year-over-year to -$17.2 million; the TTM figure through Mar 2026 stood at $66.7 million (up 250.71% YoY), while the FY2025 annual figure was $67.1 million, up 205.25% from the prior year.
• Profit After Tax for Q1 2026 stood at -$17.2 million, up from -$24.6 million in the prior quarter.
• The five-year high for Profit After Tax was $113.7 million in Q2 2025, with the low at -$31.6 million in Q1 2024.
• The 5-year median for Profit After Tax is -$11.8 million (2023), against an average of -$6.1 million.
• The sharpest annual moves came in 2023 and 2025: Profit After Tax plunged 306.49% in 2023, then jumped 1434.8% in 2025.
• Abeona Therapeutics' Profit After Tax stood at -$7.2 million in 2022, then tumbled by 130.24% to -$16.6 million in 2023, then surged by 43.99% to -$9.3 million in 2024, then sank by 164.37% to -$24.6 million in 2025, then grew by 29.85% to -$17.2 million in 2026.
• Business Quant data shows ABEO's Profit After Tax at -$17.2 million in Q1 2026, -$24.6 million in Q4 2025, and -$5.2 million in Q3 2025.